
3.45 BATS BZX Real-Time Price As of 11:18am ET | ![]() Today’s Change | 1.41 Today|||52-Week Range 4.14 | +85.22% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +74.17% increase from the last price of 3.45.
The current consensus among 5 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.